APA aipamena

Zhang, X., Goel, V., & Robbie, G. J. (2019). Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis. J Clin Pharmacol.

Chicago Style aipamena

Zhang, Xiaoping, Varun Goel, and Gabriel J. Robbie. "Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis." J Clin Pharmacol 2019.

MLA aipamena

Zhang, Xiaoping, Varun Goel, and Gabriel J. Robbie. "Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis." J Clin Pharmacol 2019.